Global healthcare and life sciences team honored for work with client GlaxoSmithKline plc.
Latham offers life sciences and healthcare industry leaders deep sector knowledge, legal expertise, and commercial and government insight to meet client needs.
Latham’s cross-disciplinary healthcare and life sciences team delivers insightful, practical guidance and sophisticated representation to a full spectrum of companies across the globe, on every type of transaction or dispute a company may face. Many of us hold advanced scientific degrees and have served in senior positions as government regulators, C-Suite executives in leading healthcare and life sciences companies, as well as serving as primary outside counsel for key industry associations.
We regularly navigate commercial and regulatory issues related to the Food and Drug Administration, the Patent Trial and Appeals Board, the European Medicines Agency, the European Commission, and other state, and federal agencies in the US and across Europe.
- The right team. We work with companies at every stage of development, from fast-growing startups to mature public companies, in virtually every sector and subsector of the industry – including healthcare services, biotechnology, medtech and medical devices. With an outstanding global platform, we can scale our client teams to meet client needs — whether that means drawing on best-of-the-best capabilities in public company representation, M&A, capital markets, regulatory advice or IP and securities litigation.
- Insight. Our broad client base and on-the-ground presence in the world’s healthcare and life sciences hubs afford us an expansive view of the commercial, scientific, regulatory, and political trends shaping the markets in which clients operate. We know how traditional regulatory regimes work, and quickly set the bar for successful strategies in dynamic and uncertain regulatory landscapes.
- Results. By leveraging decades of experience and a culture of innovation, we have developed an impressive track record navigating many of the industry’s largest, most complex, and most consequential deals through commercial and regulatory issues, as well as winning precedent-setting litigation and trials.